The company specializes in developing innovative methods for controlling gene expression and cell fate. Their breakthrough technology allows for the fast and efficient reprogramming of somatic cells into pluripotent stem cells, which can be used to produce patient-specific cells for transplantation. This technology has broad applications in personalized regenerative medicine. Additionally, Factor Bioscience is also focused on gene editing and nucleic-acid delivery technologies, enabling them to target diseases at the molecular level. The company values unlimited discovery and supports scientists in pursuing their ideas.